The impact of the reclusion on patients with blepharospasm during the COVID19 pandemic

BACKGROUND: Blepharospasm (BS) is a focal dystonia that can be treated successfully with Botulinum toxin (BoNT). During the reclusion due to the Covid 19 pandemic many patients missed the scheduled treatment. OBJECTIVES: Aim of the study is to evaluate Level of Disability (LoD) related to BS during...

Descripción completa

Detalles Bibliográficos
Autores principales: Trinchillo, Assunta, Iorillo, Filippo, De Joanna, Gabriella, Habetswallner, Francesco, Esposito, Marcello
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier B.V. 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9270186/
https://www.ncbi.nlm.nih.gov/pubmed/35907350
http://dx.doi.org/10.1016/j.clineuro.2022.107363

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9270186/
https://www.ncbi.nlm.nih.gov/pubmed/35907350
http://dx.doi.org/10.1016/j.clineuro.2022.107363

Ejemplares similares